Keratin 13 (KRT13) (N-Term) Peptide
-
- Target See all Cytokeratin 13 (KRT13) products
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KRT13 antibody (Catalog #: ARP42030_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
- Background
-
KRT13 is a member of the keratin gene family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. Most of the type I cytokeratins consist of a
Alias Symbols: CK13, K13, MGC161462, MGC3781
Protein Interaction Partner: KRT7
Protein Size: 420 - Molecular Weight
- 46 kDa
- Gene ID
- 3860
- NCBI Accession
- NM_002274, NP_002265
-